Show & Exhibition Gateway 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Show & Exhibition Gateway 2012
Your online Gateway to industry shows and expositions in 2012.
Jan 1, 2012

3M Drug Delivery Systems
View profile

Abbott Laboratories
View profile

AdvantaPure
View profile

Allegheny Bradford Corporation
View profile

AMRI
View profile

Aptalis Pharmaceutical Technologies
View profile

Baxter BioPharma Solutions
View profile

Brabender Pharma
View profile

Brookfield Engineering Laboratories
View profile

Cambridge Major Laboratories
View profile

Corden Pharma
View profile

Dwyer Instruments Inc.
View profile

Eurofins Lancaster Laboratories
View profile

Fluid Metering
View profile

FOSS NIRSystems, Inc
View profile

GE Analytical Instruments
View profile

Gemü Valves
View profile

Grand River Aseptic Manufacturing
View profile

Hamilton Company
View profile

Hospira One 2 One
View profile

I Holland Limited
View profile

International Centre for Diffraction Data
View profile

Jost Chemical Co
View profile

Labconco Corporation
View profile

Magnetrol
View profile

Meissner Filtration Products
View profile

Metrics, Inc.
View profile

MPI Research
View profile

Natoli Engineering Company, Inc.
View profile

Perfex
View profile

Rommelag
View profile

Ropack Inc.
View profile

Sartorius Stedim Biotech
View profile

Schenck AccuRate
View profile

Sensient Pharmaceutical Coating Systems
View profile

Shimadzu Scientific Instruments
View profile

Stäubli
View profile

Swagelok Company
View profile

Veltek Associates
View profile

Vetter
View profile

WellSpring Pharmaceutical Canada Corp
View profile

W.S. Tyler
View profile

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Featured Jobs

More Jobs
1/1/2012
 Click here